Trials / Completed
CompletedNCT04748562
Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies
Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies: a Randomised Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
It is already known that the risk of preterm labor in twin pregnancy before 37 week is 8-9 fold higher compared to singletons, and progesterone supplementation can decrease the incidence of preterm labor in singleton pregnancy. There were studies that used 200mg vaginal progesterone with no effect on the result So this study aims To examine the effect of prophylactic vaginal progesterone 400mg v.s 200mg for prevention of preterm birth in twin pregnancies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone | Taking prontogest vaginally |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-08-01
- Completion
- 2020-12-01
- First posted
- 2021-02-10
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04748562. Inclusion in this directory is not an endorsement.